183.11
Overview
News
Price History
Option Chain
Financials
Why HUM Down?
Discussions
Forecast
Dividend History
Humana Inc stock is traded at $183.11, with a volume of 1.43M.
It is up +0.84% in the last 24 hours and down -4.66% over the past month.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
See More
Previous Close:
$181.58
Open:
$181.29
24h Volume:
1.43M
Relative Volume:
0.76
Market Cap:
$22.08B
Revenue:
$126.36B
Net Income/Loss:
$1.30B
P/E Ratio:
17.16
EPS:
10.6697
Net Cash Flow:
$1.55B
1W Performance:
+4.00%
1M Performance:
-4.66%
6M Performance:
-41.31%
1Y Performance:
-30.32%
Humana Inc Stock (HUM) Company Profile
Name
Humana Inc
Sector
Industry
Phone
(502) 580-1000
Address
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, CI, ELV, CNC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HUM
Humana Inc
|
183.11 | 21.90B | 126.36B | 1.30B | 1.55B | 10.67 |
|
UNH
Unitedhealth Group Inc
|
291.96 | 261.98B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
80.57 | 102.40B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
CI
Cigna Group
|
284.74 | 74.81B | 274.88B | 6.29B | 8.39B | 22.19 |
|
ELV
Elevance Health Inc
|
291.45 | 62.69B | 199.13B | 5.66B | 3.17B | 25.11 |
|
CNC
Centene Corp
|
44.99 | 21.55B | 178.19B | 2.05B | 1.08B | 4.0447 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-02-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-07-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-05-25 | Upgrade | Jefferies | Hold → Buy |
| Oct-14-25 | Initiated | Goldman | Sell |
| Sep-22-25 | Initiated | Evercore ISI | In-line |
| May-01-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-06-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Oct-08-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-07-24 | Downgrade | Jefferies | Buy → Hold |
| Oct-07-24 | Downgrade | TD Cowen | Buy → Hold |
| Oct-03-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-02-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-02-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-22-24 | Initiated | Raymond James | Mkt Perform |
| Mar-13-24 | Downgrade | Argus | Buy → Hold |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Jan-26-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-25-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-23 | Upgrade | Argus | Hold → Buy |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-07-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-23-23 | Downgrade | Argus | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Oct-26-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-20-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Initiated | Bernstein | Mkt Perform |
| Apr-13-22 | Upgrade | UBS | Neutral → Buy |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-04-21 | Reiterated | Barclays | Overweight |
| Nov-04-21 | Reiterated | Credit Suisse | Outperform |
| Nov-04-21 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-21 | Reiterated | Oppenheimer | Outperform |
| Nov-04-21 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Sep-09-21 | Resumed | Barclays | Overweight |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jan-04-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-02-20 | Initiated | Bernstein | Mkt Perform |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-16-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jun-05-20 | Initiated | Goldman | Buy |
| Jan-03-20 | Reiterated | JP Morgan | Overweight |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-12-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Apr-23-19 | Initiated | UBS | Neutral |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-20-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-08-18 | Reiterated | BofA/Merrill | Buy |
| Sep-13-18 | Initiated | Barclays | Overweight |
| Jul-12-18 | Resumed | Morgan Stanley | Overweight |
| Jul-06-18 | Reiterated | Piper Jaffray | Overweight |
| Jun-01-18 | Resumed | Citigroup | Buy |
| Feb-08-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-08-18 | Reiterated | Leerink Partners | Outperform |
| Jan-12-18 | Upgrade | Jefferies | Hold → Buy |
View All
Humana Inc Stock (HUM) Latest News
Humana partners with Disabled American Veterans for the sixth year - GlobeNewswire
William Blair Investment Management LLC Purchases 27,684 Shares of Humana Inc. $HUM - MarketBeat
Humana Inc. $HUM Position Reduced by Handelsbanken Fonder AB - MarketBeat
Is It Time To Reassess Humana (HUM) After Its Steep Share Price Slide - Yahoo Finance
Humana’s Joe Morales on building trusted benefits relationships in Austin - The Business Journals
Humana Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Humana Foundation: $5 Million Commitment To Reduce Veteran Suicide Through Face The Fight - Pulse 2.0
Humana Foundation gives $5 million to veterans organization - The Business Journals
Humana Adds New Partnerships to Cardiac Care Program - marketscreener.com
Humana (HUM) Expands Cardiac Care Partnerships for Medicare Adva - GuruFocus
Humana Introduces New Value-Based Cardiology Care Partnerships for Medicare Advantage Members - The AI Journal
Here’s Why Humana Stock Has a 270% Long-Term Upside Case - TIKR.com
Humana Foundation Increases Investment to Help End the Veteran Suicide Crisis - Business Wire
South Dakota Investment Council Lowers Position in Humana Inc. $HUM - MarketBeat
What Humana (HUM)'s Dividend Hike and MaxHealth Deal Mean For Shareholders - simplywall.st
Humana’s Long Climb: Navigating The 4-STAR Recovery And The J-Curve (NYSE:HUM) - Seeking Alpha
Is the Options Market Predicting a Spike in Humana Stock? - Nasdaq
HUM Stock Quote Price and Forecast - CNN
Humana Inc. (HUM) Stock Analysis: Exploring A 17.5% Upside Potential For Investors - DirectorsTalk Interviews
Humana Inc. (HUM) Reaffirms 2026 Earnings Guidance - GuruFocus
Humana Reaffirms 2026 Earnings Guidance in Investor Meetings - TipRanks
Humana reaffirms FY 2026 guidance of $8.89 EPS, $9.00 adjusted EPSSEC filing - marketscreener.com
Humana reaffirms 2026 earnings guidance ahead of investor meetings - StreetInsider
Humana (NYSE: HUM) reiterates FY 2026 GAAP and Adjusted EPS targets - Stock Titan
Retro Louisville: Humana Building design draws mixed reactions in 1985 - The Courier-Journal
Humana Inc. (HUM): A Bull Case Theory - Insider Monkey
How Investors May Respond To Humana (HUM) Balancing Dividends With MaxHealth Deal Amid Margin Pressures - Yahoo Finance
Humana’s MaxHealth Deal Tests Medicare Advantage Strategy And Valuation Gap - Yahoo Finance
Mitsubishi UFJ Asset Management Co. Ltd. Raises Stock Holdings in Humana Inc. $HUM - MarketBeat
Humana (HUM) Valuation Check After Prolonged Share Price Weakness And Regulatory Scrutiny - simplywall.st
Humana Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Market Watch Rx: Moderna Remains Amongst Top Gainers | PharmExec - Pharmaceutical Executive
Humana Statement on our Contract with Moffitt Health System - Humana
UnitedHealth vs. Humana: Which Healthcare Stock Has More Upside Now? - InsuranceNewsNet
WA seniors scramble amid insurance dispute - The Seattle Times
Zacks Research Issues Positive Outlook for Humana Earnings - MarketBeat
Humana stock jumps 6% as Medicare Advantage enrollment report puts HUM back in focus - TechStock²
Artisan Partners Limited Partnership Sells 28,849 Shares of Humana Inc. $HUM - MarketBeat
Humana Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Barclays Lowers Humana (HUM) Price Target amid Questions on Margin Expansion Outlook - Finviz
RBC Capital Initiates Blackstone (BX) Coverage with $179 Target on Strong Growth Outlook - Finviz
Humana Tower in Louisville to be Converted into Convention Hotel - Architectural Record
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Humana Inc. to Present at the 2026 Leerink Partners Global Healthcare Conference - Business Wire
Humana (NYSE: HUM) president exercises stock options and withholds shares for taxes - Stock Titan
Humana Inc (HUM) Trading 3.08% Higher on Feb 26 - GuruFocus
Has The Humana (HUM) Share Slump Opened Up A Valuation Opportunity Now - simplywall.st
FY2028 Earnings Estimate for Humana Issued By Zacks Research - MarketBeat
3 Reasons HUM Has Explosive Upside Potential - Finviz
For Joe Morales of Humana Group Benefits, relationships make the difference in San Antonio - The Business Journals
10 best health insurance companies in the US - Insurance Business
Humana Inc Stock (HUM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):